Biolipox Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $135M

Biolipox General Information

Description

Provider of drugs for inflammatory diseases. The company is focused on therapies for inflammatory diseases including pain management and respiratory diseases like asthma and chronic obstructive pulmonary disease.

Contact Information

Website
biolipox.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Berzelius väg 3
  • plan 5
  • 171 65 Solna
  • Sweden
+46 08-524
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • Berzelius väg 3
  • plan 5
  • 171 65 Solna
  • Sweden
+46 08-524

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biolipox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 23-Nov-2007 $135M Completed Generating Revenue
4. Later Stage VC (Series C) 10-Oct-2005 Completed Startup
3. Grant 26-Feb-2005 Completed Startup
2. Early Stage VC (Series B) 22-Jan-2003 $22.1M $26.5M Completed Startup
1. Early Stage VC (Series A) 01-Mar-2001 $4.43M $4.43M Completed Startup
To view Biolipox’s complete valuation and funding history, request access »

Biolipox Patents

Biolipox Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201507752-D0 New compounds and uses Inactive 06-May-2015
GB-201507753-D0 New compounds and uses Inactive 06-May-2015
GB-201407596-D0 New compounds and uses Inactive 30-Apr-2014
GB-201407599-D0 New compounds and uses Inactive 30-Apr-2014
GB-201307201-D0 New compounds and uses Inactive 22-Apr-2013
To view Biolipox’s complete patent history, request access »

Biolipox Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biolipox Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Apax Partners PE/Buyout Minority
Auriga Partners (Paris) Venture Capital Minority
Credit Lyonnais Private Equity PE/Buyout Minority
HealthCap Venture Capital Minority
Scandinavian Life Science Venture Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Biolipox Investments (1)

Biolipox’s most recent deal was a Corporate Asset Purchase with Inflazyme Pharmaceuticals (Research & Development assets) for . The deal was made on 19-Nov-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Inflazyme Pharmaceuticals (Research & Development assets) 19-Nov-2007 Corporate Asset Purchase Buildings and Property
To view Biolipox’s complete investments history, request access »

Biolipox FAQs

  • When was Biolipox founded?

    Biolipox was founded in 2000.

  • Where is Biolipox headquartered?

    Biolipox is headquartered in Solna, Sweden.

  • What is the size of Biolipox?

    Biolipox has 9 total employees.

  • What industry is Biolipox in?

    Biolipox’s primary industry is Drug Discovery.

  • Is Biolipox a private or public company?

    Biolipox is a Private company.

  • What is the current valuation of Biolipox?

    The current valuation of Biolipox is .

  • What is Biolipox’s current revenue?

    The current revenue for Biolipox is .

  • How much funding has Biolipox raised over time?

    Biolipox has raised $67.5M.

  • Who are Biolipox’s investors?

    Apax Partners, Auriga Partners (Paris), Credit Lyonnais Private Equity, HealthCap, and Scandinavian Life Science Venture are 5 of 6 investors who have invested in Biolipox.

  • When was Biolipox acquired?

    Biolipox was acquired on 23-Nov-2007.

  • Who acquired Biolipox?

    Biolipox was acquired by Orexo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »